MedPath

Lactobacillus

Generic Name
Lactobacillus

Overview

No overview information available.

Indication

主要用于消化不良以及场内异常发酵,小儿饮食不当引起的腹泻及营养不良等;也用于使用抗生素及放、化疗后引起的菌群失调性腹泻及急性肠胃炎、腹泻、痢疾等。

Associated Conditions

No associated conditions information available.

Research Report

Published: Aug 12, 2025

Lactobacillus as a Therapeutic Agent: A Comprehensive Clinical and Microbiological Review

Section 1: The Lactobacillus Genus: Foundational Biology and Evolving Taxonomy

This section establishes the fundamental biological identity of [Lactobacillus] and addresses the recent, significant shift in its taxonomy, a crucial framework for interpreting the scientific and clinical research discussed in this report.

1.1 Core Biological and Metabolic Characteristics

[Lactobacillus] is a genus of Gram-positive, rod-shaped, non-spore-forming bacteria belonging to the phylum Firmicutes.[1] They are typically catalase-negative, facultatively anaerobic or microaerophilic, meaning they can thrive in environments with little to no oxygen.[1] A key characteristic is their high tolerance for acidic conditions, which is fundamental to their role in fermented foods and their ability to survive transit through the low pH environment of the human stomach to reach the intestines.[3]

The defining feature of the genus is its metabolism of carbohydrates to produce lactic acid, making it the largest and most prominent group within the Lactic Acid Bacteria (LAB).[1] Based on their metabolic pathways and end-products, lactobacilli are traditionally divided into three functional groups [1]:

Continue reading the full research report

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/08/27
Not Applicable
Completed
Dharmais National Cancer Center Hospital
2025/03/12
Not Applicable
Active, not recruiting
Chang Gung Memorial Hospital
2024/08/19
Phase 2
ENROLLING_BY_INVITATION
National Institute of Pediatrics, Mexico
2024/06/21
Not Applicable
Recruiting
2023/08/03
Phase 2
Recruiting
2023/04/11
Phase 4
Recruiting
2023/01/27
Phase 4
Completed
2022/10/13
Phase 3
Recruiting
2022/06/22
Phase 2
Recruiting
2022/02/24
Phase 1
UNKNOWN
Dr. Soetomo General Hospital

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
INTESTALIFE
holista health (canada) inc.
02232997
Capsule - Oral
3.4 B
8/1/1997
FERMALAC ECC 1B
institut rosell inc.
00351547
Capsule (Enteric-Coated) - Oral
0.7 B
12/31/1960

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
MUVAGYN 10E8 UFC/10E8 UFC CAPSULAS VAGINALES DURAS
Casen Recordati S.L.
88680
CÁPSULA VAGINAL DURA
Sin Receta
Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.